Vital Farms, Inc. (VITL) SEC Filings & Earnings Calls
EquiReason read 10 Vital Farms, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-08-06 — Vital Farms reported Q2 2026 net revenue down 10.1% to $166.0M, gross margin collapsed to 6.6% from 38.9%, net loss of $31.1M vs prior net income, and reiterated FY2026 guidance fo.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 392.4M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
6 Aug 20268-K · 1.01, 1.02, 2.02, 2.03, 8.01Vital Farms reported Q2 2026 net revenue down 10.1% to $166.0M, gross margin collapsed to 6.6% from 38.9%, net loss of $31.1M vs prior net income, and reiterated FY2026 guidance for revenue $775-800M and adjusted EBITDA $0-10M.earningsopen
Figures in the filing · each found in the filing text
| Net Revenue · Q2-2026 | $166M | -10% y/y |
| Gross Margin · Q2-2026 | 6.6% | |
| Net Loss · Q2-2026 | $-31M | |
| Adjusted EBITDA · Q2-2026 | $-27M | |
| Net Loss per Diluted Share · Q2-2026 | $-0.72 |
Guidance
Net revenue outlook $775M-$800M, Adjusted EBITDA $0M-$10M
Company reiterates full-year 2026 net revenue and adjusted EBITDA outlook despite weak Q2.
Risks flagged
Industry-wide oversupply and price gap pressure severely impacted revenue and margins.
“industry-wide oversupply and price gap pressure” · word for word
Gross margin collapsed due to excess breaker sales and butter business exit costs.
“Gross Margin of 6.6%, compared to 38.9%” · word for word
6 Aug 202610-QVital Farms reported a significant Q2 2026 earnings miss with revenue -10% YoY, a large net loss of $31.1M, a debt covenant breach, and announced capex reductions and product discontinuation.open
Figures in the filing · each found in the filing text
| Net revenue · Q2-2026 | $166M | -10% y/y |
| Net loss · Q2-2026 | $-31M | |
| Shell egg % of revenue · Q2-2026 | 92.0% |
Guidance
Reducing planned capital expenditures; halting Vital Crossroads construction; pausing accelerator farm development
Company cut capex guidance and paused expansion plans due to oversupply and margin pressure. No explicit revenue or EPS guidance provided, but the tone is clearly negative.
Risks flagged
Covenant breach
“As of June 28, 2026, we were not in compliance with the fixed charge coverage ratio covenant under the JPMorgan Credit Facility, and we were required to obtain a waiver of such noncompliance from our lenders.” · word for word
Oversupply and margin compression
“During the 13-week period ended June 28, 2026, our gross margin declined significantly, driven by increased cost of goods sold, industry-wide oversupply of commodity shell eggs, increased price gaps with competing products and declining shell egg velocities.” · word for word
Revenue decline
“Our net revenue decreased from $184.8 million in the 13-week period ended June 29, 2025 to $166.0 million in the 13-week period ended June 28, 2026.” · word for word
Capex reduction and halted expansion
“In May 2026, we announced that we would be proactively reducing our planned capital expenditures for the 2026 fiscal year, including halting construction on Vital Crossroads by the end of the 2026 fiscal year and pausing development of new accelerator farms.” · word for word
Product discontinuation
“We announced in May 2026 our plans to discontinue our butter product offerings, which we expect to occur by the end of fiscal year 2026.” · word for word
7 May 20268-K · 2.02, 2.05Released earnings results and quarterly financials; approved costs associated with restructuring, layoffs, or exit activitiesearningsopen
Risks flagged
Costs of discontinuation not yet estimable; may incur additional unanticipated costs.
“The Company is not able to estimate the amount or range of amounts of such potential costs... The Company may also incur additional costs not currently contemplated.”
7 May 202610-QNet revenue $187M (+15% y/y); Net (loss) income $-2M (-109% y/y); Shell egg revenue as % of net revenue 93; Guidance: reducing planned capital expenditures for 2026, slowing construction on Vital Crossroads, pausing development of new accelopen
Figures in the filing · each found in the filing text
| Net revenue · Q1-2026 | $187M | +15% y/y |
| Net (loss) income · Q1-2026 | $-2M | -109% y/y |
| Shell egg revenue as % of net revenue · shell eggs · Q1-2026 | 93.0% |
Guidance
reducing planned capital expenditures for 2026, slowing construction on Vital Crossroads, pausing development of new accelerator farms
Company is cutting capex and pausing expansion due to demand weakness and oversupply, indicating a cautious outlook.
Risks flagged
Egg Oversupply and Margin Pressure
“During 2026, the shell egg industry has experienced an increase in production and subsequent oversupply of commodity shell eggs. We have incurred costs associated with storage or donation of excess products or other supply-control measures, which has resulted in reduced margins.” · word for word
Avian Influenza Outbreak Risk
“if a substantial portion of our farms or production facilities were affected by an outbreak of HPAI, EDS or a similar disease, this could have a material and adverse effect on our business, financial condition and results of operations.” · word for word
Consumer Demand Sensitivity to Price Gaps
“We have seen such increased price differences in fiscal 2026, which we believe may have led to lower sales volume relative to our projections in the first quarter of fiscal 2026.” · word for word
Concentration Risk in Shell Eggs
“Shell eggs accounted for approximately 93% of our net revenue in the 13-week periods ended March 29, 2026.”
27 Apr 2026DEF 14AAnnual proxy statement filed, disclosing executive compensation, governance updates, and FY2025 financial highlights.open
Figures in the filing · each found in the filing text
| Net Revenue · FY2025 | $759M | +25% y/y |
| Gross Profit · FY2025 | $286M | |
| Adjusted EBITDA · FY2025 | $114M | |
| Net Income · FY2025 | $66M | |
| Aided Brand Awareness · FY2025 | 34.0% | |
| Number of Farms in Network · FY2025 | 600 |
Risks flagged
Concentration in egg supply chain
“The more than 600 family farms that supply our shell eggs are the foundation of our supply chain.” · word for word
Execution risk on new facility
“We also advanced construction at Vital Crossroads, our next facility in Seymour, Indiana.” · word for word
26 Feb 202610-KNet income $66M (+24% y/y); Adjusted EBITDA $114M (+32% y/y); Cash, cash equivalents and marketable securities $113Mopen
Figures in the filing · each found in the filing text
| Net income · FY2025 | $66M | +24% y/y |
| Adjusted EBITDA · FY2025 | $114M | +32% y/y |
| Cash, cash equivalents and marketable securities · 2025-12-28 | $113M | |
| Net cash provided by operating activities · FY2025 | $34M | -48% y/y |
Risks flagged
Tariff cost pressure
“Current or future tariffs or other restrictive trade measures may further raise the costs of raw materials, components or our products, which may adversely impact both our product offerings and our operational expenses.” · word for word
Food safety and recall risk
“Food safety and food-borne illness incidents or advertising or product mislabeling may materially and adversely affect our business by exposing us to lawsuits, product recalls or regulatory enforcement actions, increasing our operating costs and reducing demand for our product offerings.” · word for word
Climate change impact on supply
“If climate change has a negative effect on agricultural productivity, we may be subject to decreased availability or less favorable pricing for certain raw materials that are necessary for our products, including corn, soybean meal and other feed ingredients.” · word for word
26 Feb 20268-K · 2.02, 5.02, 7.01, 8.01Net Revenue $759M (+25% y/y); Net Revenue $214M (+29% y/y); Gross Margin 37.6; Guidance: FY2026 net revenue guidance $900-920M (up to 21% growth from FY2025 $759.4M), adjusted EBITDA $105-115M, capex $140-150Mearningsopen
Figures in the filing · each found in the filing text
| Net Revenue · FY2025 | $759M | +25% y/y |
| Net Revenue · Q4-2025 | $214M | +29% y/y |
| Gross Margin · FY2025 | 37.6% | |
| Gross Margin · Q4-2025 | 35.8% | |
| Net Income · FY2025 | $66M | +24% y/y |
| Net Income · Q4-2025 | $16M | +54% y/y |
| Adjusted EBITDA · FY2025 | $114M | +32% y/y |
| Adjusted EBITDA · Q4-2025 | $29M | +53% y/y |
| Share Repurchase Authorization · point_in_time | $100M |
Guidance
FY2026 net revenue guidance $900-920M (up to 21% growth from FY2025 $759.4M), adjusted EBITDA $105-115M, capex $140-150M
Strong guidance raise with 21% revenue growth, but capex increase and slight margin pressure from scaling investments. Management confident in reaching $2B revenue by 2030.
Risks flagged
Gross margin pressure from scaling investments may persist.
“Gross profit margin decreased slightly compared to the fourth quarter of 2024 as investments were made to continue to scale and grow the business” · word for word
Leadership transition risk with founder/exec chair resignation.
“Matthew O’Hayer... resignation as Executive Chairperson... effective February 24, 2026”
16 Dec 20258-K · 7.01Net Revenue $755M; Adjusted EBITDA $115M; Guidance: FY2025 revenue raised to $755-765M; 2026 initial outlook $930-950Mopen
Figures in the filing · each found in the filing text
| Net Revenue · FY2025 | $755M | |
| Adjusted EBITDA · FY2025 | $115M |
Guidance
FY2025 revenue raised to $755-765M; 2026 initial outlook $930-950M
Company raised FY2025 revenue guidance and provided strong long-term targets, indicating accelerating demand and margin expansion.
Risks flagged
ERP transition disruption temporarily impacted order patterns, but hypercare phase exited.
“Temporary disruption in returning to regular order patterns following the company’s enterprise resource planning (ERP) system transition” · word for word
4 Nov 20258-K · 2.02Net Revenue $199M (+37% y/y); Gross Margin 37.7; Net Income $16M (+122% y/y); Guidance: Net revenue at least $775M (from $770M), Adjusted EBITDA at least $115M (from $110M)earningsopen
Figures in the filing · each found in the filing text
| Net Revenue · Q3-2025 | $199M | +37% y/y |
| Gross Margin · Q3-2025 | 37.7% | |
| Net Income · Q3-2025 | $16M | +122% y/y |
| Net Income per Diluted Share · Q3-2025 | $0.36 | +125% y/y |
| Adjusted EBITDA · Q3-2025 | $27M | +80% y/y |
| Family Farms · Q3-2025 | 575 | |
| FY2025 Net Revenue Guidance · FY2025 | $775M | +28% y/y |
| FY2025 Adjusted EBITDA Guidance · FY2025 | $115M | +33% y/y |
Guidance
Net revenue at least $775M (from $770M), Adjusted EBITDA at least $115M (from $110M)
Raised FY2025 guidance on strong Q3 performance, with revenue growth of at least 28% and EBITDA growth of at least 33%
Risks flagged
Elevated capex and inventory build may pressure near-term cash flow
“Capital expenditures $44.0M YTD vs $10.5M prior year, net cash provided by operating activities $27.9M vs $50.0M prior year”
4 Nov 202510-QVital Farms reported strong Q3 2025 revenue growth of 37% YoY, driven by premium egg demand, but faces ongoing disease and input cost risks.earningsopen
Figures in the filing · each found in the filing text
| Net revenue · Q3-2025 | $199M | +37% y/y |
| Shell eggs as % of revenue · Shell eggs · Q3-2025 | 93.0% | |
| UNFI revenue concentration · Q3-2025 | 24.0% |
Risks flagged
Avian influenza and disease outbreak risk
“A total of nine of our farms experienced outbreaks of EDS in fiscal 2024 and 11 of our farms have experienced outbreaks of EDS to date in fiscal 2025.” · word for word
Customer concentration
“UNFI accounted for approximately 24% and 24% of our net revenue in the 13-week periods ended September 28, 2025 and September 29, 2024, respectively.”
Input cost volatility
“The price we pay to purchase shell eggs from contracted farmers fluctuates based on pallet weight and is also adjusted quarterly for changes in feed cost.” · word for word
Single-source packaging supplier
“We obtain substantially all of the packaging for our shell eggs from a sole source supplier.” · word for word
Vital Farms, Inc. — questions
- What did Vital Farms, Inc. file recently?
- 10 SEC filings in the last 12 months. Latest: 8-K on 2026-08-06 — Vital Farms reported Q2 2026 net revenue down 10.1% to $166.0M, gross margin collapsed to 6.6% from 38.9%, net loss of $31.1M vs prior net income, and reiterated FY2026 guidance for revenue $775-800M and adjusted EBITDA $0-10M.
Every figure on this page comes from Vital Farms, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.